Immuno-Oncology Frontiers World is an intimate and exclusive partnering event placing the next frontier of I-O in a strategic context whilst giving you direct access to the decision makers and key opinion leaders working towards the next oncology blockbuster.
Dr. Vanessa Lucey, associate director, CRI Venture Fund & Clinical Accelerator, Cancer Research Institute, speaks during the "Back to Basics: The Road Map to Rationalising Combination Trial Designs for Clinical Success" session on January 23, 2018 at 2:00 p.m.
The event will take place at Hyatt Regency Miami, 400 SE 2nd Ave, Miami, FL 33131.